항생제 내성 진단 시장 규모, 점유율 및 성장 분석 : 검사 유형별, 기술별, 병원체별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Antimicrobial Resistance Diagnostics Market size was valued at USD 4.52 Billion in 2024 and is poised to grow from USD 4.92 Billion in 2025 to USD 9.85 Billion by 2033, growing at a CAGR of 8.82% during the forecast period (2026-2033).

The global market for antimicrobial resistance diagnostics is significantly influenced by the escalating issue of antibiotic resistance among pathogens and evolving healthcare policies. These diagnostics encompass a variety of assays and technologies designed for detecting pathogens and their resistance profiles, which facilitate targeted treatments and effective antibiotic stewardship. The reliance on broad-spectrum antibiotics has intensified the urgency for precise diagnostics to combat resistance, mortality, and associated healthcare costs. The transition from traditional culture methods to advanced technologies-such as PCR and next-generation sequencing-enhances detection capabilities. Increasing regulatory support and favorable compensation models further stimulate market growth by encouraging adoption and investment. Innovations in rapid and point-of-care testing not only ensure timely interventions but also reduce hospital stays and healthcare costs, fostering a continuous cycle of advancement in the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Antimicrobial Resistance Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Antimicrobial Resistance Diagnostics Market Segments Analysis

Global antimicrobial resistance diagnostics market is segmented by test type, technology, pathogen, end-user and region. Based on test type, the market is segmented into Genotypic Tests (PCR, NGS), Phenotypic Tests (Culture & Sensitivity) and Rapid Diagnostic Tests (RDTs). Based on technology, the market is segmented into PCR-Based, Microarray-Based and Mass Spectrometry (MALDI-TOF). Based on pathogen, the market is segmented into Bacteria (MRSA, ESBL), Fungi and Mycobacteria (TB). Based on end-user, the market is segmented into Hospitals, Clinical Laboratories and Public Health Labs. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Antimicrobial Resistance Diagnostics Market

One key market driver for the global antimicrobial resistance diagnostics market is the rising prevalence of multidrug-resistant infections. As bacteria evolve and develop resistance to commonly used antibiotics, healthcare systems face increasing challenges in effectively managing infections. This scenario not only leads to higher morbidity and mortality rates but also escalates healthcare costs due to prolonged hospital stays and the need for more expensive treatment options. Consequently, there is a growing demand for rapid and accurate diagnostic tools that can promptly identify resistant pathogens, enabling healthcare professionals to make informed decisions about appropriate therapies and ultimately improve patient outcomes.

Restraints in the Global Antimicrobial Resistance Diagnostics Market

One key market restraint for the global antimicrobial resistance diagnostics market is the high cost associated with the development and deployment of advanced diagnostic technologies. The complexity of these diagnostics often requires significant investment in research and development, as well as sophisticated laboratory infrastructure and skilled personnel. Additionally, the integration of these diagnostics into existing healthcare systems can be challenging due to budget constraints and varying levels of acceptance among healthcare providers. This financial burden can limit accessibility, particularly in low and middle-income countries, thereby hindering widespread adoption and reducing the overall market potential.

Market Trends of the Global Antimicrobial Resistance Diagnostics Market

The Global Antimicrobial Resistance Diagnostics market is witnessing a transformative trend characterized by the expansion of point-of-care testing. This shift towards compact and user-friendly diagnostic tools, deployed outside traditional laboratory settings, is increasingly prioritized due to the demand for rapid and actionable results at the bedside and in outpatient environments. Such advancements facilitate early targeted therapies, bolster antimicrobial stewardship, and extend testing capabilities to underserved community and resource-limited areas. Manufacturers are focused on enhancing workflow efficiency, user experience, and connectivity for clinical decision support, driven by a growing preference among payers and providers for solutions that expedite appropriate treatment and integrate with electronic health systems.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Antimicrobial Resistance Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Genotypic Tests (PCR, NGS)
• Phenotypic Tests (Culture & Sensitivity)
• Rapid Diagnostic Tests (RDTs)

Global Antimicrobial Resistance Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• PCR-Based
• Microarray-Based
• Mass Spectrometry (MALDI-TOF)

Global Antimicrobial Resistance Diagnostics Market Size by Pathogen & CAGR (2026-2033)

• Market Overview
• Bacteria (MRSA, ESBL)
• Fungi
• Mycobacteria (TB)

Global Antimicrobial Resistance Diagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Clinical Laboratories
• Public Health Labs

Global Antimicrobial Resistance Diagnostics Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, Pathogen, End-User)
  • US
  • Canada
• Europe (Test Type, Technology, Pathogen, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, Pathogen, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, Pathogen, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, Pathogen, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (Danaher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OpGen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vela Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ELITechGroup
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bruker Corporation (MALDI-TOF)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accelerate Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Specific Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• T2 Biosystems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Mindray
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin SpA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations